在HIV-1蛋白酶/抑制剂复合体中的界面水的有约束力的自由能量贡献
Yipin Lu1, Chao-Yie Yang, Shaomeng Wang
1Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA.
Journal of the American Chemical Society
|September 7, 2006
概括
界面的水分子显著影响蛋白质-连接体结合的自由能量. 它们的贡献有所不同,受蛋白质残留和抑制剂的影响,这对药物设计至关重要.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 计算化学计算化学
背景情况:
- 蛋白质-连接体复合体中的水分子对于结合相互作用至关重要.
- 量化界面水的能量贡献对于理解结合至关重要.
- 影响水媒结合的因素需要在药物设计中阐明.
研究的目的:
- 量化评估单个界面水分子的结合性自由能量贡献.
- 为了研究蛋白质质子状态和抑制剂对水的贡献的影响.
- 了解接口水在HIV-1蛋白酶抑制剂相互作用中的作用.
主要方法:
- 利用双解的自由能量分子动力学模拟方法.
- 计算了四个界面水分子的结合性自由能量贡献.
- 分析了催化酸残留质子化状态 (Asp25,Asp125) 和不同抑制剂的影响.
主要成果:
- 在四个界面水分子中,有两种对结合自由能量有显著的贡献.
- 其他两个水分子的自由能量贡献几乎为零.
- 保存的水分子Wat301的贡献受到Asp25/Asp125质子和抑制剂类型的强烈影响.
结论:
- 界面水分子在蛋白质-连接体结合能量学中起着不同的作用.
- 关键残留物和抑制剂选择的质子化状态调节水的贡献.
- 研究结果通过突出结合水界面相互作用的重要性,为基于结构的药物设计提供了信息.
相关概念视频
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


